P-glycoprotein (P-gp) is a well-known membrane transporter expressed in a number of strategic biological barriers, where it exerts a protective effect of paramount importance. Conversely it is one of the main causes of multidrug resistance (MDR), being capable of effluxing many chemotherapeutics. In a development of previous research, a small library of compounds was created conjugating diversely substituted furazan rings with MC70, a well-known P-gp inhibitor. These compounds were assessed for their potency against P-gp and another transporter (MRP1), for their apparent permeability (Papp) and for their ability to induce ATPase activity, thus delineating a complete functional profile. They displayed a substrate mechanism of action and high selectivity toward P-gp, unlike the lead compound. Data relating to their activity range from low micromolar to sub-nanomolar EC50, the most interesting compounds being 15 (0.97 nM), 19 (1.3 nM), 25 (0.60 nM), and 27 (0.90 nM).

Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein

GUGLIELMO, Stefano
First
;
LAZZARATO, Loretta;CHEGAEV, Konstantin;FRUTTERO, Roberta;GASCO, Alberto
2016-01-01

Abstract

P-glycoprotein (P-gp) is a well-known membrane transporter expressed in a number of strategic biological barriers, where it exerts a protective effect of paramount importance. Conversely it is one of the main causes of multidrug resistance (MDR), being capable of effluxing many chemotherapeutics. In a development of previous research, a small library of compounds was created conjugating diversely substituted furazan rings with MC70, a well-known P-gp inhibitor. These compounds were assessed for their potency against P-gp and another transporter (MRP1), for their apparent permeability (Papp) and for their ability to induce ATPase activity, thus delineating a complete functional profile. They displayed a substrate mechanism of action and high selectivity toward P-gp, unlike the lead compound. Data relating to their activity range from low micromolar to sub-nanomolar EC50, the most interesting compounds being 15 (0.97 nM), 19 (1.3 nM), 25 (0.60 nM), and 27 (0.90 nM).
2016
59
14
6729
6738
http://pubs.acs.org/jmc
Molecular Medicine; Drug Discovery3003 Pharmaceutical Science
Guglielmo, Stefano; Lazzarato, Loretta; Contino, Marialessandra; Perrone, Maria G.; Chegaev, Konstantin; Carrieri, Antonio; Fruttero, Roberta; Colabufo, Nicola A.; Gasco, Alberto
File in questo prodotto:
File Dimensione Formato  
acs%2Ejmedchem%2E6b00252(4).pdf

Accesso riservato

Descrizione: articolo principale ad accesso riservato
Tipo di file: PDF EDITORIALE
Dimensione 3.88 MB
Formato Adobe PDF
3.88 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
SAR Studies on Tetrahydroisoquinoline Derivatives_revised _4aperto.pdf

Open Access dal 02/10/2017

Descrizione: articolo principale
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 945.5 kB
Formato Adobe PDF
945.5 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1600244
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 18
social impact